Nuclear factor kappa B

Context

NF-kB sits inactive in the cytoplasm of most cells, bound to inhibitor proteins (IkB family). When the cell receives an activating signal (cytokines, ROS, mechanical stress, microbial components), IkB is phosphorylated and degraded, releasing NF-kB to translocate into the nucleus. There, NF-kB binds specific DNA sequences (kappa B sites) in the promoters of inflammatory genes and drives their transcription.

The genes under NF-kB control in joint tissue include IL-1, IL-6, TNF-alpha, COX-2, iNOS, and MMP-13. Activation of NF-kB is therefore not a single effect, it is the upstream switch that turns on a coordinated inflammatory program.

Why it matters for joint health

NF-kB is the pharmacological rationale behind curcumin's role in joint support. Curcumin attenuates NF-kB activation at multiple points in the pathway, reducing the downstream transcription of the inflammatory and degradative genes. This is an upstream intervention: a single modulator reduces the output of many downstream inflammatory mediators. It is also the reason curcumin works on a slow timeline (weeks), unlike NSAIDs which act on the terminal COX output directly.